← Back to Search

Treatment for Inclusion Body Myositis (INSPIRE-IBM Trial)

N/A
Waitlist Available
Led By Tahseen Mozaffar, MD FAAN, FANA
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to month 24
Awards & highlights
No Placebo-Only Group

Summary

This is a prospective natural history study on patients with clinically defined sIBM. Participants will be assessed every 6 months over two years (five visits total). We will include 150 participants, enrolled across 13 sites, with sporadic IBM, diagnosed according to established criteria.

Eligible Conditions
  • Inclusion Body Myositis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to month 24
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to month 24 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Forced Vital Capacity (FVC) (sitting)
Frequency of immunophenotypic abnormalities in blood and muscle
Inclusion Body Myositis Functional Rating Scale (IBMFRS)
+1 more
Secondary study objectives
EAT-10 Questionnaire
Forced Vital Capacity (supine)
Hand Held Dynamometry
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Find a Location

Who is running the clinical trial?

University of California, IrvineLead Sponsor
560 Previous Clinical Trials
1,929,902 Total Patients Enrolled
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
494 Previous Clinical Trials
1,089,292 Total Patients Enrolled
Tahseen Mozaffar, MD FAAN, FANAPrincipal InvestigatorUniversity of California, Irvine
~44 spots leftby Jan 2026